Tag Archives: Lunsumio (mosunetuzumab)

Roche Presents Promising Data on Innovative Lymphoma Treatments at ASH Annual Meeting

(IN BRIEF) Roche, a global pharmaceutical company, has shared compelling data from its CD20xCD3 T-cell engaging bispecific antibody program during the 65th American Society of Hematology (ASH) Annual Meeting & Exposition held in December 2023. The data includes extended follow-up … Read the full press release